Is Alzheimer’s Disease a Liver Disease of the Brain?
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Clinical specialization is not only a force for progress, but it has also led to the fragmentation of medical knowledge. The focus of research in the field of Alzheimer's disease (AD) is neurobiology, while hepatologists focus on liver diseases and lipid specialists on atherosclerosis. This article on AD focuses on the role of the liver and lipid homeostasis in the development of AD. Amyloid-β (Aβ) deposits accumulate as plaques in the brain of an AD patient long before cognitive decline is evident. Aβ generation is a normal physiological process; the steady-state level of Aβ in the brain is determined by balance between Aβ production and its clearance. We present evidence suggesting that the liver is the origin of brain Aβ deposits and that it is involved in peripheral clearance of circulating Aβ in the blood. Hence the liver could be targeted to decrease Aβ production or increase peripheral clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig.1 Some factors altering the balance between amyloid Aβ production and clearance leading to dyshomeostasis. Peripheral clearance can remove 40–50% of Aβ burden in the brain [25, 26]. Aβ, amyloid-β; AβPP, amyloid-β protein precursor, LRP1, low-density lipoprotein receptor-related peptide 1; LDLR, low-density-lipoprotein receptor; P-gp, P-glycoprotein.](https://figures.cochat.ai/paper-figures/06233310ef5d43cd8f768f053c5fa4bf/is-alzheimers-disease-a-liver-disease-of-the-brain-figure-1.jpg)
![Fig.2 Schematic representation of Alzheimer’s disease homeostasis showing amyloid-β (Aβ) production from amyloid-β protein precursor (AβPP) in the liver, dysregulated influx/efflux across blood-brain barrier (BBB) (1), transport in serum via soluble LRP1 (2) and exosomes [61] and saturable uptake of Aβ by liver via low-density lipoprotein receptor-related peptide 1 (LRP1) and low-density-lipoprotein receptor (LDLR) (3) with subsequent biliary clearance. RAGE, receptor for advanced glycation end products.](https://figures.cochat.ai/paper-figures/686adf0fd74c48389a6937bd7a50f794/is-alzheimers-disease-a-liver-disease-of-the-brain-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, this capacity decreases with age, which is partially attributed to the low expression of low-density lipoprotein receptor-related protein 1 (LRP-1) in hepatocytes.227–229”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [228]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“typified by deposition of A within the brain [3, 4].”
BackgroundSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 1×
“Studies on sleep raise the possibility that altering sleep quality might impact A deposition and may also regulate the clearance of A from the brain [63].”
BackgroundQuerfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · cited 1×
“typified by deposition of A within the brain [3, 4].”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“A number of subsequent studies suggest that ApoE4 inhibits A clearance and/or is less efficient in mediating A peripheral clearance compared with ApoE3 and ApoE2 [47] (reviewed in [48, 49]).”
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,108
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611 · cited 13×
“HCV may cross the BBB leading to neuroinflammation and neuropsychiatric symptoms [115].”
BackgroundInfluential
Cited by
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
“3, a leaky BBB contributes to accumulation of Aβ in the brain (Estrada et al., 2019; Bassendine et al., 2020).”
Virus exposure and neurodegenerative disease risk across national biobanks
Levine, K. S., Leonard, H. L., Blauwendraat, C., Iwaki, H., Johnson, N., Bandres-Ciga, S., Ferrucci, L., Faghri, F., Singleton, A. B., & Nalls, M. A. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.029 · Cited by 341
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Bruno, F., Abondio, P., Bruno, R., Ceraudo, L., Paparazzo, E., Citrigno, L., Luiselli, D., Bruni, A. C., Passarino, G., Colao, R., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102068 · Cited by 88
Couteur, D. G. L., Ngu, M., Hunt, N. J., Brandon, A. E., Simpson, S. J., & Cogger, V. C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01099-z · Cited by 89
“…or dementia in people with type 2 diabetes aged 60 years or more 169 . β-Amyloid, the presumptive pathogenic protein in Alzheimer disease, might be cleared by the liver 170 or perhaps even produced by the liver 171 , providing a geroscience-based link between the ageing liver and dementia 172 .”
Wiȩckowska-Gacek, A., Mietelska-Porowska, A., Chutorański, D., Wydrych, M., Długosz, J., & Wojda, U. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654509 · Cited by 71
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Ferrell, J. M., & Chiang, J. Y. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.07.002 · Cited by 76
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites
Kalecký, K., German, D. C., Montillo, A. A., & Bottiglieri, T. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215448 · Cited by 62
“Lipotoxicity is further implicated in liver disease and microbiome dysbiosis [94], and in turn, liver disease is sometimes considered a contributor to AD [95].”
BackgroundKim, Y., Lim, J., & Oh, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117277 · Cited by 70
Brain organoids are new tool for drug screening of neurological diseases
Zhou, J.-Q., Zeng, L., Li, C.-T., He, D.-H., Zhao, H.-D., Xu, Y., Jin, Z.-T., & Gao, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367983 · Cited by 54
“For example, the liver has been strongly suggested as the key contributor to different neurological diseases like AD, PD, and depression (Mohamed et al., 2014; Ciulla et al., 2019; Bassendine et al., 2020).”
BackgroundShi, M., Chu, F., Zhu, F., & Zhu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03003-5 · Cited by 54
“…mice, the animal model for AD, decreased significantly, and liver cell necrosis as well as lymphocyte infiltration increased obviously compared to wild type mice [36], which indicates that the liver plays important roles in the pathogenesis of AD through affecting on Aβ metabolism [32, 37, 38].”
BackgroundLiver integrity and the risk of Alzheimer's disease and related dementias
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13601 · Cited by 50
“3 However, animal studies have shown that NAFLD, even in the absence of obesity and hyperglycemia, can promote inflammation and neuronal apoptosis, cerebral hypoperfusion, and brain amyloid deposition.”
BackgroundElevated C-reactive protein mediates the liver-brain axis: a preliminary study
Jiang, R., Wu, J., Rosenblatt, M., Dai, W., Rodriguez, R. X., Sui, J., Qi, S., Liang, Q., Xu, B., Meng, Q., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104679 · Cited by 46
Tang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45
Autophagy and Alzheimer’s Disease: Mechanisms and Impact Beyond the Brain
Hein, Z. M., Vishnumukkala, T., Karikalan, B., Alkatiri, A., Hussan, F., Jagadeesan, S., Kamaruzzaman, M. A., Ramli, M. D. C., Nassir, C. M. N. C. M., & Gopalakrishna, P. K. (2025) · Cells · doi:10.3390/cells14120911 · Cited by 42
“Autophagy activation by A β 42 appears to be initially protective; however, prolonged activation can shift to a pro-death role, contributing to neuronal degeneration [126].”
Liu, Q., Liu, C., Hu, F., Deng, X., & Zhang, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.738835 · Cited by 41
“Reduced LRP1 expression in patients with NAFLD leads to decreased peripheral Aβ protein clearance, which ultimately exacerbates amyloid load (25, 30).”
BackgroundLow Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study
Lü, Y., Pike, J. R., Selvin, E., Mosley, T. H., Palta, P., Sharrett, A. R., Thomas, A. G., Loehr, L. R., Barritt, A. S., Hoogeveen, R. C., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201241 · Cited by 40
“Our results support the arguments that hepatic functionality should be considered for further insights into brain health and amyloid-(cid:2) balance [31, 42].”
Integrated Liver and Plasma Proteomics in Obese Mice Reveals Complex Metabolic Regulation
Stocks, B., González-Franquesa, A., Borg, M. L., Björnholm, M., Niu, L., Zierath, J. R., & Deshmukh, A. S. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100207 · Cited by 40
Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice
Giannisis, A., Patra, K., Edlund, A. K., Nieto, L. A., Benedicto-Gras, J., Moussaud, S., de la Rosa, A., Twohig, D., Bengtsson, T., Fu, Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01548-0 · Cited by 41
“Furthermore, the livers of AD patients exhibit altered levels of amyloid-β degrading enzymes [48] and Bassendine and colleagues speculated that AD is a liverdisease of the brain [49].”
BackgroundMetabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis
Vegas‐Suárez, S., Simón, J., Martínez‐Chantar, M. L., & Moratalla, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.864263 · Cited by 40
Association between liver fibrosis and incident dementia in the UK Biobank study
Parikh, N. S., Kamel, H., Zhang, C., Kumar, S. R., Rosenblatt, R. E., Spincemaille, P., Gupta, A. K., Cohen, D. E., de Leon, M. J., Gottesman, R. F., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15437 · Cited by 38
Parikh, N. S., Kamel, H., Zhang, C., Gupta, A. K., Cohen, D. E., de Leon, M. J., Gottesman, R. F., & Iadecola, C. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12795 · Cited by 30
Geerts, H., Walker, M., Rose, R., Bergeler, S., van der Graaf, P. H., Schuck, E. L., Koyama, A., Yasuda, S., Hussein, Z., Reyderman, L., et al. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12912 · Cited by 29
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 28
Liu, N., Haziyihan, A., Zhao, W. G., Chen, Y., & Chao, H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00434-9 · Cited by 28
“Recent studies have shown that AD is associated with abnormal liver function [115].”
BackgroundYang, H., Liao, Z., Zhou, Y., Gao, Z., & Mao, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1375379 · Cited by 27
“The liver is the origin of brain A β deposits and is involved in the peripheral clearance of plasma A β through enzymes, albumin and lipid metabolism (15).”
BackgroundCerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
Hadjihambi, A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114387 · Cited by 27
Garcia, J., Chang, R., Steinberg, R. A., Arce, A., Yang, J., Eb, P. V. D., Abdullah, T., Chandrashekar, D. V., Eck, S. M., Meza, P., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.930402 · Cited by 27
“This may be true regarding Aβ homeostasis, where the liver is involved in Aβ clearance from blood and peripheral organs (Ghiso et al., 2004; Tamaki et al., 2006; Wang et al., 2017; Bassendine et al., 2020), but is also a potential source for Aβ in the periphery and blood, which can ultimately accumulate in the brain (…”
BackgroundWeinstein, G., Schonmann, Y., Yeshua, H., & Zelber‐Sagi, S. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14033 · Cited by 26
Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
Lam, S. C. C., Arif, M., Song, X., Uhlén, M., & Mardinoğlu, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.889728 · Cited by 26
“…which are normally associated with liver disease, such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), and bilirubin, confirming the possibility of a role for the liver-brain axis in NLDs such as AD, as previously reported (Bassendine et al., 2020; Jakhmola-Mani et al., 2021).”
BackgroundPeng, Z., Duggan, M. R., Dark, H. E., Daya, G. N., An, Y., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A., & Walker, K. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.004 · Cited by 25
Wu, B., Liu, Y., Li, H., Zhu, L., Zeng, L., Zhang, Z., & Peng, W. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391305 · Cited by 24
“Metabolomic findings from APP/PS1 mouse models indicate that the liver, which significantly accumulates Aβ (Bassendine et al., 2020), appears to be the first organ affected by amyloid pathology (Zheng et al., 2019).”
BackgroundImmune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 23
“Notably, the liver’s involvement in A β metabolism has been underscored in AD pathology, with studies showing alterations in liver function and A β clearance in AD transgenic mice [70].”
Herrero-Labrador, R., Trueba-Sáiz, Á., Martinez‐Rachadell, L., de Sevilla, M. E. F., Zegarra-Valdivia, J. A., Pignatelli, J., Díaz-Pacheco, S., Fernandez, A. M., & Torres‐Alemán, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249675 · Cited by 23
“Thus, the relationship between peripheral and central Aβ is still under debate [44]; indeed, a substantial part of brain Aβ clearance in humans takes place in the periphery [45], and reduction of peripheral Aβ reduces its content in the CSF [46].”
BackgroundLiver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study
Lampignano, L., Donghia, R., Griseta, C., Lagravinese, G., Sciarra, S., Zupo, R., Castellana, F., Bortone, I., Guerra, V., Tirelli, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.748888 · Cited by 22
Hunt, N. J., Wahl, D., Westwood, L. J., Lockwood, G. P., Couteur, D. G. L., & Cogger, V. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114537 · Cited by 21
“It has been proposed that targeting the liver with pharmacotherapies that increase hepatic clearance of Aβ might treat or prevent AD [27].”
BackgroundZuffa, S., Allaband, C., Charron‐Lamoureux, V., Caraballo‐Rodríguez, A. M., Patan, A., Mohanty, I., Agongo, J., Bostick, J. W., Connerly, T. J., Thron, T., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117499 · Cited by 20
Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Área-Gómez, E., & Schon, E. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231318 · Cited by 20
Babygirija, R., Han, J. H., Sonsalla, M. M., Matoska, R., Calubag, M. F., Green, C. L., Tobon, A., Yeh, C., Vertein, D., Schlorf, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62416-3 · Cited by 18
“We observedsigni fi cantchangesinmetabolicpathwaysinresponsetodiet in females, with some overlap in the response to DL and CR feeding, while males showed many fewer changes with no overlapping changes between the DL and CR groups.”
Liver function and Alzheimer's brain pathologies: A longitudinal study
Kim, J. W., Byun, M. S., Yi, D., Jung, J. H., Kong, N., Chang, Y. Y., Jung, G., Ahn, H., Lee, J.-Y., Kang, K. M., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100012 · Cited by 18
Callahan, B. L., Plamondon, A., Gill, S., & Ismail, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-03782-y · Cited by 17
Basu, E., Mehta, M., Zhang, C., Zhao, C., Rosenblatt, R. E., Tapper, E. B., & Parikh, N. S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120117 · Cited by 17
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209203 · Cited by 17
Wang, H., Zhang, L., Xia, Z., & Cui, J. Y. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000453 · Cited by 16
“There has been evidence suggesting that the liver is the origin of the brain amyloid-b (Ab) deposition and is involved in the peripheral clearance of circulating Ab in the blood (Bassendine et al., 2020).”
BackgroundDarabi, S., Gorgich, E. A. C., Moradi, F., & Rustamzadeh, A. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.01.004 · Cited by 15
Wang, J., Meng, X., Jialun, Y., Tang, Y., Zeng, F., Wang, Y., Chen, Z., Chen, D., Zou, R., & Liu, W. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04350-w · Cited by 15
“This creates a tight bidirectional liver–brain axis [ 134, 135 ].”
Sun, T., Feng, M., Manyande, A., Xiang, H., Xiong, J., & He, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1206417 · Cited by 15
Wei, J., Hu, L., Xu, S., Yang, F., Liao, F., Tang, Y., Shen, X., Zhang, X., Fang, X., Li, Y., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03487-3 · Cited by 14
“Emerging evidence indicates that the liver is a key peripheral organ involved in this process, with inflammatory mediators from the liver reaching the brain via the circulatory system, a phenomenon referred to as the liver ‒ brain axis [7, 8].”
Modeling neurodegenerative diseases with brain organoids: from development to disease applications
Larriba-González, T., García-Martín, M., Ojeda-Hernández, D. D., Rincón-Cerrada, P., Martín-Blanco, L., Benito‐Martín, M. S., Selma-Calvo, B., de la Fuente-Martín, S., Matías‐Guiu, J. A., Matías‐Guiu, J., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1663286 · Cited by 13
Serum amyloid beta 42 levels correlated with metabolic syndrome and its components
Li, K., Zhou, X., Liu, Y., Li, D., Li, Y., Zhang, T., Fu, C., Li, L., Hu, Y., & Jiang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1278477 · Cited by 12
Kimura, N., Sasaki, K., Masuda, T., Ataka, T., Matsumoto, M., Kitamura, M., Nakamura, Y., & Matsubara, E. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01650-1 · Cited by 12
Associations of liver function with plasma biomarkers for Alzheimer’s Disease
Zhang, B., Zhang, C., Wang, Y., Cheng, L., Wang, Y., Qiao, Y., Peng, D., & Initiative, A. D. N. (2024) · Neurological Sciences · doi:10.1007/s10072-023-07284-9 · Cited by 12
“The liver is a major metabolic and degradation organ of the body, which is involved in the clearance of various substances including Aβ [7, 8].”
The contributions of bacteria metabolites to the development of hepatic encephalopathy
Gilbert, M. C., Setayesh, T., & Wan, Y. Y. (2022) · Liver Research · doi:10.1016/j.livres.2022.11.005 · Cited by 11
Ko, J. W., Lee, Y., Jang, Y., & Kwon, Y. H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106022 · Cited by 11
Past, Present, and Future of Liver-Brain Axis in Alzheimer’s Disease: A Bibliometric Review
Liu, X. L., Yeerlan, J., Liu, Z., Bai, Y., Wang, Q., Yan, Y., Xu, L., Cui, J., & Zhang, L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240688 · Cited by 10
“48 Schindler et al. demonstrated a positive correlation between systemic levels of A (cid:2) in the blood and both the amyloid accumulation in the brain and cognitive deterioration in AD.”
Lim, T. S., Chung, S. J., Jeon, J., Kim, J. K., & Kim, J. (2025) · Gut and Liver · doi:10.5009/gnl250079 · Cited by 10
“Moreover, evidence suggests that the liver is involved in brain β -amyloid deposits as well as peripheral clearance of circulating β -amyloid in the blood, 37 which may contribute to the pathogenesis of dementia.”
Braissant, O., McLin, V. A., Sessa, D., & Pierzchała, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-21054-x · Cited by 10
“Few studies have explored this link 4,5 , some suggesting an impairment of Aβ clearance by liver 6 .”
InfluentialDai, J., Xu, Y., Wang, T., & Zeng, P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110700 · Cited by 10
Pinheiro, F. I., Araújo-Filho, I., Rêgo, A. C. M., de Azevedo, E. P., Cobucci, R. N., & Gúzen, F. P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102250 · Cited by 10
Türkez, H., Altay, Ö., Yıldırım, S., Li, X., Yang, H., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121325 · Cited by 10
RetractedCheng, Y., Jian, J.-M., He, C.-Y., Ren, J.-R., Xu, M., Jin, W., Tan, C., Zeng, G., Shen, Y., Chen, D., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220126 · Cited by 9
“Furthermore, several studies suggested the potential of FABP1 in circulating blood as a biomarker for hepatic damage and indicated that elevated blood FABP1 levels were a prognostic factor for survival in chronic liver disease [29, 30], a condition closely related to AD [31].”
Altay, Ö., Yang, H., Yıldırım, S., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., Hacımüftüoğlu, A., Shoaie, S., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12040927 · Cited by 9
“It also influences other critical cellular processes such as calcium homeostasis and apoptotic pathways, further exacerbating neuronal damage [3,4].”
BackgroundCao, X., Chen, Y., Sang, X., Xu, S., Xie, Z., Zhu, Z., Wang, P., Bi, J., & Xu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1013943 · Cited by 8
How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?
Afşar, E., & Kantar, D. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127589 · Cited by 8
Zhang, Y., Guo, K., Zhang, P., Zhang, M., Li, X., Zhou, S., Sun, H., Wang, W., Wang, H., & Hu, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.942203 · Cited by 8
Bhattacharjee, A., & Roy, P. K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2154842 · Cited by 8
“Several reports suggest that the primary organ that has the largest amyloid-beta deposit is the liver (Bassendine et al., 2020).”
BackgroundEnrichment of liver MAIT cells in a mouse model of Alzheimer's disease
Wyatt-Johnson, S. K., Kersey, H. N., & Brutkiewicz, R. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578332 · Cited by 7
Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory
Liu, S., Huang, Y.-N., Park, T., Lee, E. H., Chaudhuri, S., Adzibolosu, N. K., Bice, P. J., Dage, J. L., Brosch, J. R., Gao, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70851 · Cited by 7
Gross, S., Danielyan, L., Buechler, C., Kubitza, M., Klein, K., Schwab, M., Melter, M., & Weiß, T. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168768 · Cited by 7
“PHHs were isolated and maintained in culture, as described earlier [46].”
BackgroundMethodInfluentialAssociation of Serum Liver Enzymes with Brain Amyloidopathy and Cognitive Performance
Han, S., Lee, S., Kim, J. H., Lee, J., Park, Y. H., Kim, S., Nho, K. T., & Sohn, J. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230148 · Cited by 7
“Although the etiology of AD remains complex and multifactorial, recent evidence has shed light on the potential interactions between the brain and peripheral organs, particularly the liver, in regulating A (cid:2) homeostasis [3–6].”
Detection of Amyloid‐β Peptides in Gingival Crevicular Fluid and Its Effect on Oral Pathogens
Liao, Y., Chen, H., Qiu, C., Shen, H., He, Z., Song, Z., & Zhou, W. (2024) · Molecular Oral Microbiology · doi:10.1111/omi.12488 · Cited by 6
Gaps in dementia knowledge: a nationwide study of public awareness and misconceptions in Bulgaria
Lazarova, S., & Petrova‐Antonova, D. (2025) · Psychogeriatrics · doi:10.1111/psyg.70016 · Cited by 6
M’Bra, P. E. H., Hamilton, L. K., Moquin‐Beaudry, G., Mangahas, C. L., Pratesi, F., Castonguay, A., Mailloux, S., Galoppin, M., Lopez, J. A., Bernier, M., et al. (2025) · Brain · doi:10.1093/brain/awaf267 · Cited by 6
“14,16 In addition to its neuroprotective changes in the brain, MCT supplementation also had beneficial effects on glucose metabolism, peripheral insulin response and the hepatic transcriptome.”
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
“[117]).”
Hung, K., Chen, S., Hsu, P., Lin, B., Hu, C., Yang, C.-H., Pai, T., Tzou, W., & Chung, H. (2022) · Genes · doi:10.3390/genes13061096 · Cited by 6
“showed that amyloid-β (Aβ), the main biomarker of Alzheimer’s disease, was originally generated in the liver [59].”
BackgroundZhang, D., Wang, Z., Wang, X., Yue, W., Zhang, L., Gao, Z., Li, M., Zhou, X., Li, Z., Huang, G., et al. (2025) · Lipids · doi:10.1002/lipd.12436 · Cited by 5
“Next, we analyzed the mRNA and protein levels of LRP1 and LDLR in the brain and liver because LRP1 combined with LDLR mediates brain – blood A β clearance through hepatic metabolism pathways (Bassendine et al., 2020).”
Gong, W., Hui, W., Qiao, S., Ji, Q., Liu, M., Zhang, B., Liu, D., Wu, Y., & Zhou, S. (2026) · Advanced Science · doi:10.1002/advs.202523458 · Cited by 5
“Growing evidence indicates that the liver plays a critical role in peripheral A β clearance and inflammatory regulation [ 11–13 ].”
Han, S., Lee, S., Kim, J. H., Lee, J., Park, Y. H., Kim, S., Nho, K. T., & Sohn, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1411466 · Cited by 5
“Recent investigations have focused on the potential interactions between the brain and peripheral organs, particularly the liver, in relation to A β clearance (Estrada et al., 2019; Bassendine et al., 2020; Cheng et al., 2020; Huang et al., 2022).”
BackgroundHerrero-Labrador, R., Trueba-Sáiz, Á., Martinez‐Rachadell, L., de Sevilla, M. E. F., Zegarra-Valdivia, J. A., Díaz-Pacheco, S., Fernandez, A. M., & Torres‐Alemán, I. (2020) · Research Square · doi:10.21203/rs.3.rs-60930/v1 · Cited by 5
“Thus, the relationship between peripheral and central Aβ is still under debate [50]; indeed, a substantial part of brain Aβ clearance in humans takes place in the periphery [51].”
BackgroundZhou, J., Sun, X., Wang, K., Shen, M., Yu, J., Yao, Q., Hong, H. S., Tang, C., & Wang, Q. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01399-z · Cited by 4
“An imbalance in peripheral and brain Aβ production and clearance may link AD to non-neurological diseases [16].”
Deciphering the role of liver metabolic enzymes in dementia pathogenesis
Li, K., Zhang, J., Hong, H., Jiaerken, Y., Tu, Y., Wu, X., Ding, B., Yang, Z., Zeng, Q., Luo, X., et al. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100019 · Cited by 5
Hovhannisyan, Y., Yeritsyan, H., Hakobjanyan, G., Petrosyan, G., Harutyunyan, H. A., Muradyan, A. A., Azizian, A., & Yenkoyan, K. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146965 · Cited by 4
“Several studies have highlighted that liver pathologies can impair the liver’s ability to eliminate beta-amyloid from the bloodstream [69], promoting its accumulation in the brain and potentially contributing to Alzheimer’s disease [60].”
Looking at the periphery—new hypothesis to look for new targets for Alzheimer’s disease therapy
Ávila, J., Pérez, M., Ávila‐Villanueva, M., Santa‐María, I., & Hernández, F. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00044 · Cited by 4
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Qiao, M., Ni, J., Qing, H., Qiu, Y., & Quan, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04779-8 · Cited by 4
“Besides the immune dialogue, substance exchange has been suggested between peripheral organs and central nervous system (CNS) [11].”
Gómez‐Pinilla, F., & Myers, S. K. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102733 · Cited by 4
“For example, the liver is the origin of А β deposits involved in Alzheimer ’ s disease pathology (Bassendine et al., 2020), and liver failure have strong influence on brain function in hepatic encephalopathy (Felipo, 2013).”
Restifo, L. L., & Erickson, R. P. (2023) · SAGE Open Medical Case Reports · doi:10.1177/2050313x231194507 · Cited by 4
Petre, A. M., Thieschafer, J. S., Palsuledesai, C. C., Cornille, K., Chang, A., Li, L., & Distefano, M. D. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00320 · Cited by 3
Geng, C., Gao, P., & Tang, Y. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105845 · Cited by 3
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients
Zhao, C., Li, T., Hao, S., Zhao, L., Han, Y., & Cai, Y. (2025) · Journal of Neurology · doi:10.1007/s00415-024-12824-0 · Cited by 3
“Evidence suggests that the liver, which exhibits significant circadian cycling in about 10% of its transcripts, serves as both a source of Aβ deposits and plays a role in the peripheral clearance of Aβ [44–46].”
Genome-wide imputed differential expression enrichment analysis identifies trait-relevant tissues
Ghaffar, A., & Nyholt, D. R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1008511 · Cited by 3
“It is interesting to note that some other tissues such as liver were also highly ranked for Alzheimer’s disease and the association of liver in Alzheimer’s disease has been reported in multiple studies (Nho et al., 2019; Bassendine et al., 2020).”
ResultZhang, S., Yao, Y., Li, Y., Zhang, X., & Wu, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04985-4 · Cited by 2
“Our MR results also showed that higher genetic risk for AD can predispose individuals to higher AST2ALT ratio, increased EGFR, and decreased CRE levels, suggesting that AD exerts systemic effects beyond the nervous sys-tem, potentially involving liver and kidney function [46, 47].”
Liver aging and associated diseases
Xu, Y., Deng, Q., Chen, Y., & Wang, H. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2025-5918 · Cited by 2
Hong, S., Hong, S., & Lee, S. H. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2197761 · Cited by 2
“In a recent study, AD was suggested to be a liver disease of the brain (Bassendine et al. 2020), and impaired functional liver enzymes and brain glucose were suggested to be part of the AD diagnosis (Nho et al. 2019).”
BackgroundARI EKMEĞİNİN ALZHEİMER SIÇAN MODELİNDE KARACİĞER 5HT2B ARACILI GLUKOZ DÜZENLEMESİ ÜZERİNE ETKİSİ
Afşar, E., Doğan, K., Kantar, D., & Acun, A. D. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1433727 · Cited by 1
Afşar, E. (2026) · Kastamonu Medical Journal · doi:10.66235/kumj.1853640 · Cited by 1
Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis
Park, J., Guo, F., Lee, J. E., & Cheon, S. Y. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115899 · Cited by 1
Duffy, L. K. (2023) · Advances in Clinical Toxicology · doi:10.23880/act-16000281 · Cited by 1
Bhattacharjee, A., & Roy, P. K. (2024) · Brain Disorders · doi:10.1016/j.dscb.2023.100112 · Cited by 1
“The recent multisystemic perspective of dementia delineates that AD is a hepatic metabolic encephalopathy [43], and this can furnish a unique prospect of intervening in AD from a metabolic framework.”
Associations of Serum Liver Function with Cerebral Blood Flow in Patients with Alzheimer’s Disease
Wang, H., Shi, L., Luo, S., Luo, Y., Xu, C., Qiu, G., Guo, Q., Chen, C., Lu, T., Liu, K., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230102 · Cited by 1
“However, increasing studies demonstrated that the liver plays essential roles in the pathogenesis of AD by affecting A (cid:2) and lipids metabolism [8–10].”
BackgroundJin, H., Yang, Q., Chen, G., Zhang, W., Wu, Y., & Wang, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240148 · Cited by 1
“The liver serves as a significant metabolic and degradation organ in the body, participating in the clearance of various substances, including biomarkers associated with AD [30].”
Metadata
- Authors
- Bassendine, M. F., Taylor-Robinson, S. D., Fertleman, M., Khan, M., & Neely, D.
- Affiliations
- Imperial College London (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Bassendine, Margaret F.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-05-05
- Volume
- 75
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC7306895
- OpenAlex
- W3014127696
- Cited by
- 124
- References
- 129
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 24 · 2023: 18 · 2022: 25 · 2021: 8 · 2020: 3
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research (2011-NIHR 7068)
- Imperial College London
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, liver
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Liver, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.